Skip to main content
Medical information Clinical review pending

Cytogenetics

Chromofic Karyoarray Test

The Chromofic Karyoarray Test uses advanced microarray technology to detect chromosomal abnormalities linked to neurological disorders. It helps in early diagnosis and management.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
4 mL (2 mL minimum) whole blood collected in both a Lavender Top (EDTA) tube and a Green Top (Sodium Heparin) tube.
Results
Approximately 10 working days. Confirm with the laboratory before booking.
Preparation
No special preparation is required for the patient. Confirm with the laboratory before booking.
Test priceKSh 64,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Chromofic Karyoarray Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Developmental delays
  • ✓Intellectual disabilities
  • ✓Neurological concerns
  • ✓Family history of genetic disorders
  • ✓Suspected chromosomal abnormalities
  • ✓Unexplained congenital anomalies
02

In plain language

What this test helps you understand

Detects chromosomal abnormalities (copy number variations) associated with neurological disorders, aiding in diagnosis and management.
The Chromofic Karyoarray Test is a sophisticated genetic test designed to detect chromosomal abnormalities that may contribute to various neurological disorders. This test plays a crucial role in the early diagnosis and management of these conditions, allowing for timely interventions and tailored treatment plans.

This test utilizes the Affymetrix CytoScan 750K microarray technology to analyze the entire genome for copy number variations (CNVs) and other chromosomal alterations that may be linked to disorders of the nervous system.

Individuals who exhibit symptoms such as developmental delays, intellectual disabilities, or other neurological concerns should consider the Chromofic Karyoarray Test. Additionally, those with a family history of genetic disorders may also benefit from this test to assess potential risks.

Benefits of taking the test include early detection of genetic abnormalities, comprehensive analysis of chromosomal health, informed decision-making regarding treatment options, and peace of mind for families with a history of neurological disorders.

Results from the Chromofic Karyoarray Test will provide insights into the presence of chromosomal abnormalities. A genetic counselor or healthcare provider will help interpret the results and discuss their implications for health and treatment.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo special preparation is required for the patient. Confirm with the laboratory before booking.
Sample4 mL (2 mL minimum) whole blood collected in both a Lavender Top (EDTA) tube and a Green Top (Sodium Heparin) tube.
MethodologyAffymetrix CytoScan 750K microarray technology.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test detects copy number variations and chromosomal alterations but may not identify all genetic causes of neurological disorders. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

It's a genetic test using microarray technology to look for chromosomal abnormalities that might be linked to neurological conditions.
Individuals with developmental delays, intellectual disabilities, neurological symptoms, or a family history of genetic disorders may be recommended for this test.
A blood sample is required, collected in two specific types of tubes (Lavender Top and Green Top).
Results are typically available within 10 working days, but this can vary. Confirm with the laboratory before booking.
Results indicate the presence or absence of specific chromosomal abnormalities. A healthcare provider or genetic counselor will explain the results and their implications.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp